Obstructive Sleep Apnea as a Risk Factor for Pneumonia Among Patients Infected SARS-CoV-2: A Prop...

Obstructive Sleep Apnea as a Risk Factor for Pneumonia Among Patients Infected SARS-CoV-2: A Propensity Score-Matching Analysis  Cureus

Surveillance and Data Analytics | COVID-19 - Centers for Disease Control and Prevention | CDC (.gov)

Surveillance and Data Analytics | COVID-19  Centers for Disease Control and Prevention | CDC (.gov)

US COVID declining after reaching peak - CIDRAP

US COVID declining after reaching peak  CIDRAP

Intranasal vaccine combining adenovirus and trimeric subunit protein provides superior immunity a...

Intranasal vaccine combining adenovirus and trimeric subunit protein provides superior immunity against SARS-CoV-2 Omicron variant  Nature

The European Respiratory Virus Surveillance Summary (ERVISS) - European Centre for Disease Preven...

The European Respiratory Virus Surveillance Summary (ERVISS)  European Centre for Disease Prevention and Control

Open science yields broad-spectrum coronavirus antiviral - Medical Xpress

Open science yields broad-spectrum coronavirus antiviral  Medical Xpress

The recency and geographical origins of the bat viruses ancestral to SARS-CoV and SARS-CoV-2 - Sc...

The recency and geographical origins of the bat viruses ancestral to SARS-CoV and SARS-CoV-2  ScienceDirect.com

Wastewater Measures of SARS-CoV-2 Accurately Predict Frequency of Symptomatic Infections in the C...

Wastewater Measures of SARS-CoV-2 Accurately Predict Frequency of Symptomatic Infections in the Community  Oxford Academic

New coronavirus approach shows promise in Scripps Research study, scientists say - San Diego Unio...

New coronavirus approach shows promise in Scripps Research study, scientists say  San Diego Union-Tribune

Smell Loss May Linger for Years After COVID - Medscape

Smell Loss May Linger for Years After COVID  Medscape

Should we be worried about the current COVID-19 variants? - GOV.UK blogs

Should we be worried about the current COVID-19 variants?  GOV.UK blogs

Nearly 7 in 10 COVID survivors tested didn't know they had a dulled sense of smell - CIDRAP

Nearly 7 in 10 COVID survivors tested didn't know they had a dulled sense of smell  CIDRAP

Chronic Cardiovascular Disorders Associated With COVID-19: A Literature Review - Cureus

Chronic Cardiovascular Disorders Associated With COVID-19: A Literature Review  Cureus

SARS-CoV-2 virus lacking the envelope and membrane open-reading frames as a vaccine platform - Na...

SARS-CoV-2 virus lacking the envelope and membrane open-reading frames as a vaccine platform  Nature

Transfer of SARS-CoV-2 nucleocapsid protein to uninfected epithelial cells induces antibody-media...

Transfer of SARS-CoV-2 nucleocapsid protein to uninfected epithelial cells induces antibody-mediated complement deposition  ScienceDirect.com

COVID-NET - Centers for Disease Control and Prevention | CDC (.gov)

COVID-NET  Centers for Disease Control and Prevention | CDC (.gov)

Unveiling the structural spectrum of SARS-CoV-2 fusion by in situ cryo-ET - Nature

Unveiling the structural spectrum of SARS-CoV-2 fusion by in situ cryo-ET  Nature

COVID-19 Treatment Clinical Care for Outpatients - Centers for Disease Control and Prevention | C...

COVID-19 Treatment Clinical Care for Outpatients  Centers for Disease Control and Prevention | CDC (.gov)

Cardiovascular post-acute sequelae of SARS-CoV-2 in children and adolescents: cohort study using ...

Cardiovascular post-acute sequelae of SARS-CoV-2 in children and adolescents: cohort study using electronic health records  Nature

Association of SARS-CoV-2 vaccination status with risk of influenza-like illness and loss of work...

Association of SARS-CoV-2 vaccination status with risk of influenza-like illness and loss of workdays in healthcare workers | Communications Medicine  Nature

The Virtual Lab of AI agents designs new SARS-CoV-2 nanobodies - Nature

The Virtual Lab of AI agents designs new SARS-CoV-2 nanobodies  Nature

Could this Molecule be ‘Checkmate’ for Coronaviruses like SARS-CoV-2? - UC San Francisco

Could this Molecule be ‘Checkmate’ for Coronaviruses like SARS-CoV-2?  UC San Francisco

SARS-CoV-2 infection induces pro-fibrotic and pro-thrombotic foam cell formation - Nature

SARS-CoV-2 infection induces pro-fibrotic and pro-thrombotic foam cell formation  Nature

A systems biology approach to define SARS-CoV-2 correlates of protection - Nature

A systems biology approach to define SARS-CoV-2 correlates of protection  Nature

SARS-CoV-2 antibody responses in children exhibit higher FcR engagement and avidity than in adult...

SARS-CoV-2 antibody responses in children exhibit higher FcR engagement and avidity than in adults  Nature

Moderna says updated next-generation COVID shot shows strong immune response in patients - Reuters

Moderna says updated next-generation COVID shot shows strong immune response in patients  Reuters

National COVID-19 trends, September 23 - The Sick Times

National COVID-19 trends, September 23  The Sick Times

Survival and transmission fitness of SARS-CoV-2 over the time-of-flight in an aerosolization cham...

Survival and transmission fitness of SARS-CoV-2 over the time-of-flight in an aerosolization chamber  Nature

Tracing the spatial origins and spread of SARS-CoV-2 Omicron lineages in South Africa - Nature

Tracing the spatial origins and spread of SARS-CoV-2 Omicron lineages in South Africa  Nature

Whole-body visualization of SARS-CoV-2 biodistribution in vivo by immunoPET imaging in non-human ...

Whole-body visualization of SARS-CoV-2 biodistribution in vivo by immunoPET imaging in non-human primates  Nature

How to Protect Yourself and Others | COVID-19 - Centers for Disease Control and Prevention | CDC ...

How to Protect Yourself and Others | COVID-19  Centers for Disease Control and Prevention | CDC (.gov)

Testing for COVID-19 - Centers for Disease Control and Prevention | CDC (.gov)

Testing for COVID-19  Centers for Disease Control and Prevention | CDC (.gov)

Mucosal immune responses to SARS-CoV-2 infection and COVID-19 vaccination - ScienceDirect.com

Mucosal immune responses to SARS-CoV-2 infection and COVID-19 vaccination  ScienceDirect.com

A small-molecule SARS-CoV-2 inhibitor targeting the membrane protein - Nature

A small-molecule SARS-CoV-2 inhibitor targeting the membrane protein  Nature

Fine-scale patterns of SARS-CoV-2 spread from identical pathogen sequences - Nature

Fine-scale patterns of SARS-CoV-2 spread from identical pathogen sequences  Nature

Study Shows SARS-CoV-2 Corrupts Some White Blood Cells to Suppress Immune System, Suggesting a Pa...

Study Shows SARS-CoV-2 Corrupts Some White Blood Cells to Suppress Immune System, Suggesting a Path to Severe COVID  Johns Hopkins Medicine

Moderna: Updated COVID-19 vaccine generates strong immune response - McKnight's Long-Term Care News

Moderna: Updated COVID-19 vaccine generates strong immune response  McKnight's Long-Term Care News

Outpatient antibiotic use in COVID patients linked to 'downstream' antibiotic resistance - CIDRAP

Outpatient antibiotic use in COVID patients linked to 'downstream' antibiotic resistance  CIDRAP

COVID-19 | Yellow Book - Centers for Disease Control and Prevention | CDC (.gov)

COVID-19 | Yellow Book  Centers for Disease Control and Prevention | CDC (.gov)

SARS-CoV-2 pseudovirus dysregulates hematopoiesis and induces inflammaging of hematopoietic stem ...

SARS-CoV-2 pseudovirus dysregulates hematopoiesis and induces inflammaging of hematopoietic stem and progenitor cells | Experimental & Molecular Medicine  Nature

Antigenic and virological characteristics of SARS-CoV-2 variants BA.3.2, XFG, and NB.1.8.1 - The ...

Antigenic and virological characteristics of SARS-CoV-2 variants BA.3.2, XFG, and NB.1.8.1  The Lancet

What can we learn from millions of viral genome sequences? - Open Access Government

What can we learn from millions of viral genome sequences?  Open Access Government

Burden of Cardiovascular Outcomes After SARS-CoV-2 Infection in South Korea and Japan: A Bination...

Burden of Cardiovascular Outcomes After SARS-CoV-2 Infection in South Korea and Japan: A Binational Population-Based Cohort Study | Circulation  American Heart Association Journals

Nonhuman primate antigenic cartography of SARS-CoV-2 - ScienceDirect.com

Nonhuman primate antigenic cartography of SARS-CoV-2  ScienceDirect.com

COVID-19 vaccine guidance shifts away from universal shots - Cleveland.com

COVID-19 vaccine guidance shifts away from universal shots  Cleveland.com

WHO Scientific advisory group issues report on origins of COVID-19 - World Health Organization (WHO)

WHO Scientific advisory group issues report on origins of COVID-19  World Health Organization (WHO)

Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron - Nature

Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron  Nature

SARS-CoV-2 spike protein: structure, viral entry and variants - Nature

SARS-CoV-2 spike protein: structure, viral entry and variants  Nature

Human ACE2 transgenic pigs are susceptible to SARS-CoV-2 and develop COVID-19-like disease - Nature

Human ACE2 transgenic pigs are susceptible to SARS-CoV-2 and develop COVID-19-like disease  Nature

Plasma proteomic evidence for increased β-amyloid pathology after SARS-CoV-2 infection - Nature

Plasma proteomic evidence for increased β-amyloid pathology after SARS-CoV-2 infection  Nature

Characterisation of a persistent SARS-CoV-2 infection lasting more than 750 days in a person livi...

Characterisation of a persistent SARS-CoV-2 infection lasting more than 750 days in a person living with HIV: a genomic analysis  The Lancet

Spatial transcriptomics of the epipharynx in long COVID identifies SARS-CoV-2 signalling pathways...

Spatial transcriptomics of the epipharynx in long COVID identifies SARS-CoV-2 signalling pathways and the therapeutic potential of epipharyngeal abrasive therapy | Scientific Reports  Nature

Five years after the pandemic: Researchers are surprised by the coronavirus' development - Scienc...

Five years after the pandemic: Researchers are surprised by the coronavirus' development  ScienceNorway

Small-molecule inhibition of SARS-CoV-2 NSP14 RNA cap methyltransferase - Nature

Small-molecule inhibition of SARS-CoV-2 NSP14 RNA cap methyltransferase  Nature

Inferring effects of mutations on SARS-CoV-2 transmission from genomic surveillance data - Nature

Inferring effects of mutations on SARS-CoV-2 transmission from genomic surveillance data  Nature

Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemic - Nature

Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemic  Nature

Moderna says updated mNEXSPIKE induces strong immune response against rising COVID-19 strain - Fi...

Moderna says updated mNEXSPIKE induces strong immune response against rising COVID-19 strain  Fierce Pharma

Targeting the SARS-CoV-2 reservoir in long COVID - The Lancet

Targeting the SARS-CoV-2 reservoir in long COVID  The Lancet

Activity of Research-Grade Pemivibart against Recent SARS-CoV-2 JN.1 Sublineages - New England Jo...

Activity of Research-Grade Pemivibart against Recent SARS-CoV-2 JN.1 Sublineages  New England Journal of Medicine

Severity of respiratory syncytial virus versus SARS-CoV-2 Omicron and influenza infection amongst...

Severity of respiratory syncytial virus versus SARS-CoV-2 Omicron and influenza infection amongst hospitalized Singaporean adults: a national cohort study  The Lancet

Why Ben Affleck, Jennifer Garner's daughter Violet spoke at the United Nations - ABC News - Break...

Why Ben Affleck, Jennifer Garner's daughter Violet spoke at the United Nations  ABC News - Breaking News, Latest News and Videos

EMA Backs COVID Booster for LP.8.1, Expands to Teens - Medscape

EMA Backs COVID Booster for LP.8.1, Expands to Teens  Medscape

Virological and antigenic characteristics of SARS-CoV-2 variants LF.7.2.1, NP.1, and LP.8.1 - The...

Virological and antigenic characteristics of SARS-CoV-2 variants LF.7.2.1, NP.1, and LP.8.1  The Lancet

Lab Leak: The True Origins of Covid-19 - The White House (.gov)

Lab Leak: The True Origins of Covid-19  The White House (.gov)

Emergence and spread of the SARS-CoV-2 omicron (BA.1) variant across Africa: an observational stu...

Emergence and spread of the SARS-CoV-2 omicron (BA.1) variant across Africa: an observational study  The Lancet

Now’s a good time to get vaccinated against respiratory diseases - Park Rapids Enterprise

Now’s a good time to get vaccinated against respiratory diseases  Park Rapids Enterprise

The consequences of SARS-CoV-2 within-host persistence - Nature

The consequences of SARS-CoV-2 within-host persistence  Nature

Assessing SARS-CoV-2 Virus Levels in Sewage | US EPA - U.S. Environmental Protection Agency (.gov)

Assessing SARS-CoV-2 Virus Levels in Sewage | US EPA  U.S. Environmental Protection Agency (.gov)

SARS-CoV-2 Variant XEC Increases as KP.3.1.1 Slows - Centers for Disease Control and Prevention |...

SARS-CoV-2 Variant XEC Increases as KP.3.1.1 Slows  Centers for Disease Control and Prevention | CDC (.gov)

Origin of Covid 19: the laboratory leak is the most likely (part 3) - Inf'OGM

Origin of Covid 19: the laboratory leak is the most likely (part 3)  Inf'OGM

Pediatric COVID-19 Encephalopathy: Insights from Beijing Study - BIOENGINEER.ORG

Pediatric COVID-19 Encephalopathy: Insights from Beijing Study  BIOENGINEER.ORG

Genomic Surveillance for SARS-CoV-2 Variants: ... - Centers for Disease Control and Prevention | ...

Genomic Surveillance for SARS-CoV-2 Variants: ...  Centers for Disease Control and Prevention | CDC (.gov)

Clinical and functional assessment of SARS-CoV-2 sequelae among young marines – a panel study - T...

Clinical and functional assessment of SARS-CoV-2 sequelae among young marines – a panel study  The Lancet

Long COVID is not FND, but some patients are getting diagnosed with it. Here’s what to do if it h...

Long COVID is not FND, but some patients are getting diagnosed with it. Here’s what to do if it happens to you.  The Sick Times

Characteristics of SARS-CoV-2 and COVID-19 - Nature

Characteristics of SARS-CoV-2 and COVID-19  Nature

Researchers in Spain develop new Covid vaccine which achieved full immunisation in lab tests - Su...

Researchers in Spain develop new Covid vaccine which achieved full immunisation in lab tests  Sur in English

Transmission of SARS-CoV-2: implications for infection prevention precautions - World Health Orga...

Transmission of SARS-CoV-2: implications for infection prevention precautions  World Health Organization (WHO)

Tracking SARS-CoV-2 variants - World Health Organization (WHO)

Tracking SARS-CoV-2 variants  World Health Organization (WHO)

Acute and postacute sequelae associated with SARS-CoV-2 reinfection - Nature

Acute and postacute sequelae associated with SARS-CoV-2 reinfection  Nature

SARS-CoV-2 infection and persistence in the human body and brain at autopsy - Nature

SARS-CoV-2 infection and persistence in the human body and brain at autopsy  Nature

About COVID-19 - Centers for Disease Control and Prevention | CDC (.gov)

About COVID-19  Centers for Disease Control and Prevention | CDC (.gov)

SARS-CoV-2 pathogenesis - Nature

SARS-CoV-2 pathogenesis  Nature

SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels - ...

SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels  Nature

SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC) - Nature

SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)  Nature

Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern - World Health Organization ...

Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern  World Health Organization (WHO)

Reducing transmission of SARS-CoV-2 - Science | AAAS

Reducing transmission of SARS-CoV-2  Science | AAAS

SARS-CoV-2-specific plasma cells are not durably established in the bone marrow long-lived compar...

SARS-CoV-2-specific plasma cells are not durably established in the bone marrow long-lived compartment after mRNA vaccination  Nature

The evolution of SARS-CoV-2 - Nature

The evolution of SARS-CoV-2  Nature

Coronavirus disease (COVID-19) - World Health Organization (WHO)

Coronavirus disease (COVID-19)  World Health Organization (WHO)

Joint statement on the prioritization of monitoring SARS-CoV-2 infection in wildlife and preventi...

Joint statement on the prioritization of monitoring SARS-CoV-2 infection in wildlife and preventing the formation of animal reservoirs  World Health Organization (WHO)

Population immunity predicts evolutionary trajectories of SARS-CoV-2 - ScienceDirect.com

Population immunity predicts evolutionary trajectories of SARS-CoV-2  ScienceDirect.com

SARS-CoV-2 productively infects human gut enterocytes - Science | AAAS

SARS-CoV-2 productively infects human gut enterocytes  Science | AAAS

Cellular signaling and immune correlates for SARS-CoV-2 infection - fda.gov

Cellular signaling and immune correlates for SARS-CoV-2 infection  fda.gov

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 - New England Journal of ...

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1  New England Journal of Medicine

How lung distress from SARS-CoV-2 can cause heart damage - National Institutes of Health (NIH) | ...

How lung distress from SARS-CoV-2 can cause heart damage  National Institutes of Health (NIH) | (.gov)

Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras - New Englan...

Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras  New England Journal of Medicine

Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults - Nature

Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults  Nature

Human SARS-CoV-2 challenge uncovers local and systemic response dynamics - Nature

Human SARS-CoV-2 challenge uncovers local and systemic response dynamics  Nature

WHO-convened global study of origins of SARS-CoV-2: China Part - World Health Organization (WHO)

WHO-convened global study of origins of SARS-CoV-2: China Part  World Health Organization (WHO)

SARS-CoV-2 vaccines in development - Nature

SARS-CoV-2 vaccines in development  Nature